Bio-Techne Corp. buy Citigroup Inc.
Start price
04.02.26
/
50%
€58.50
Target price
04.02.27
-
Performance (%)
-26.24%
Price
14:05
€43.07
Summary
This prediction is currently active. The prediction for Bio-Techne Corp. disappoints with a performance of -26.24%. A total of €0.080 was paid as dividends for this prediction. This prediction currently runs until 04.02.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Techne Corp. | -7.955% | -7.955% |
| iShares Core DAX® | 0.423% | 5.706% |
| iShares Nasdaq 100 | 4.096% | 16.639% |
| iShares Nikkei 225® | 4.469% | 18.343% |
| iShares S&P 500 | 1.788% | 9.644% |
Comments by Citigroup_Inc_ for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for TECH provided by MarketBeat